NEUTROPEG pegfilgrastim 6 mg/0.6 mL solution for injection pre-filled syringe

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

Pegfilgrastim, Quantity: 6 mg

Commercializzato da:

Accord Healthcare Pty Ltd

Forma farmaceutica:

Injection, solution

Composizione:

Excipient Ingredients: glacial acetic acid; polysorbate 20; sodium hydroxide; sorbitol; water for injections

Via di somministrazione:

Subcutaneous

Confezione:

1 prefilled syringe

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

For the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

Dettagli prodotto:

Visual Identification: clear and colourless liquid; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2019-08-19